Cellectar Biosciences Inc at EBD Group Biotech Showcase Transcript
Hello, everybody, and welcome. I'm Erik Clausen with CG Life. I'll be announcing the company presentations today.
We're really thrilled. Our first and next presenting company is Cellectar Biosciences, hailing from Florham Park, New Jersey. Cellectar Biosciences is focused on hematology, oncology, orphan and rare disease. Presenting for Cellectar Biosciences is their President and CEO, James Caruso.
And please stick around afterwards. A breakout will follow on public breakout room two. Thank you.
Thank you, Erik. It's a pleasure to be here and presenting at Biotech Showcase 2024. Certainly appreciative of your participation in the presentation as well.
As you may or may not know, Cellectar Biosciences is traded on the Nasdaq Exchange under CLRB ticker symbol. Here's our obligatory Safe Harbor statement. I would always, of course, direct your attention to our public filings with the SEC.
As many of you know, Cellectar
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |